Amneal Pharmaceuticals, Inc. (“Amneal”) (Nasdaq: AMRX) announced that its subsidiary, Amneal Pharmaceuticals LLC (the “Issuer”), is seeking to borrow $1.800 billion aggregate ...

The Issuer intends to use the net proceeds of the new term B loans and the notes to refinance its existing term B loans in full, to repay a portion of outstanding amounts borrowed under its ABL ...

Unaudited Preliminary Financial Results for the Second Quarter Ended June 30, 2025 Net revenue of $720 million to $730 million, an increase of approximately 3% versus the same period in 2024 Income ...

Sanner, a 134-year-old German medical equipment maker, opens first US factory in Greensboro with advanced GMP-certified ...